These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38693730)

  • 1. Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks.
    Hassan WNM; Al-Kaabi MM; Akram NN; Kassim MAK; Pantazi AC
    Curr Med Chem; 2024; 31(30):4807-4825. PubMed ID: 38693730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.
    Bosselaar S; Dhelin L; Dautel E; Titecat M; Duthoy S; Stelmaszczyk M; Delory N; De Sousa Violante M; Machuron F; Ait-Abderrahim H; Desreumaux P; Foligné B; Monnet C
    BMC Microbiol; 2024 Jun; 24(1):233. PubMed ID: 38951788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in the Treatment of Inflammatory Bowel Diseases.
    Guandalini S
    Adv Exp Med Biol; 2024; 1449():135-142. PubMed ID: 39060735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.
    Scarpato E; Russo M; Staiano A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S7-S9. PubMed ID: 30036240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
    Ganji-Arjenaki M; Rafieian-Kopaei M
    J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics for the treatment of inflammatory bowel disease.
    Veerappan GR; Betteridge J; Young PE
    Curr Gastroenterol Rep; 2012 Aug; 14(4):324-33. PubMed ID: 22581276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease.
    Ekstedt N; Jamioł-Milc D; Pieczyńska J
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.
    Kerman DH; Deshpande AR
    Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.